Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03834025 · ClinicalTrials.gov registry record · NA
Nudges and Incentives to Enhance the Opioid Treatment Workforce
A NA study of Opioid Abuse (Disorder), sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT03834025 is a NA study of Opioid Abuse (Disorder) that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 73 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03834025, a NA study of Opioid Abuse (Disorder), has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
This project seeks to examine a critical barrier to optimizing the health care workforce for the treatment of opioid use disorders. Without a dramatic increase in the number of primary care providers trained and comfortable with the many nuances of prescribing medication-assisted treatment (MAT), the staggering increases in opioid overdose deaths will continue to skyrocket. However, Drug Addiction Treatment Act (DATA) 2000 waiver training alone is not enough to facilitate prescribing for patients who desperately need services; an estimated 40% of physicians with waivers do not initiate MAT prescriptions. To address this problem, North Carolina developed a learning collaborative framework to promote MAT training. Learning collaboratives have been shown to be an efficacious approach to increase utilization of MAT, but engagement among providers in North Carolina has been low. To date, the need to encourage provider collaborative participation at scale has not been addressed. This is the critical problem focused on in this proposal. The death rate from accidental opioid overdoses continues to climb at an alarming rate, with overdose deaths in 2016 almost five times the number from 1999. The daily death rate from opioid overdoses in the U.S. alone is now estimated at 115, so every day that evidence-based treatment is not available leads to more preventable deaths. North Carolina is one of the states with both an opioid overdose death rate greater than the national average (11.9 vs 10.4 deaths per 100,000, age-adjusted) and a rate of increase in opioid overdose deaths greater than the national average (19% vs. 16%). North Carolina is also one of four states with an Agency for Healthcare Research and Quality (AHRQ) funded Extension for Community Healthcare Outcomes (ECHO) MAT learning collaborative available to primary care practices, but engagement among providers is low. While the main barriers to engagement are incompletely understood, recent evidence from provider in
Conditions Studied
Interventions
- BEHAVIORAL Phase 1 Condition 1
- BEHAVIORAL Phase 1 Condition 2
- BEHAVIORAL Phase 1 Condition 3
- BEHAVIORAL Phase 1 Condition 4
- BEHAVIORAL Phase 2 Condition 1
Study Locations (1)
North Carolina
- University of North Carolina At Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2019-02-12 |
| Est. Completion | 2020-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03834025
The ClinicalTrials.gov registry entry for NCT03834025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Abuse (Disorder) appearing as the primary indexed condition, and to 5 interventions - of which Phase 1 Condition 1 is the first listed.
NCT03834025 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03834025 about?
NCT03834025 is a clinical study titled "Nudges and Incentives to Enhance the Opioid Treatment Workforce". This project seeks to examine a critical barrier to optimizing the health care workforce for the treatment of opioid use disorders. Without a dramatic increase in the number of primary care providers trained and comfortable with the many nuances of prescribing medication-assisted treatment (MAT), th...
What is the current status of trial NCT03834025?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2019-02-12. Estimated completion is 2020-08-28.
What conditions does trial NCT03834025 study?
This clinical trial studies the following conditions: Opioid Abuse (Disorder).
What interventions are being tested in trial NCT03834025?
The interventions under investigation include: Phase 1 Condition 1 (BEHAVIORAL), Phase 1 Condition 2 (BEHAVIORAL), Phase 1 Condition 3 (BEHAVIORAL), Phase 1 Condition 4 (BEHAVIORAL), Phase 2 Condition 1 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03834025?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03834025 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.